医疗保险处方药计划中钠-葡萄糖共转运蛋白 2 抑制剂和胰高血糖素样肽 1 受体激动剂的覆盖范围、处方限制和自付费用。
Coverage, Formulary Restrictions, and Out-of-Pocket Costs for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Medicare Part D Program.
机构信息
Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, University of Pittsburgh, Pennsylvania.
Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, University of Pittsburgh.
出版信息
JAMA Netw Open. 2020 Oct 1;3(10):e2020969. doi: 10.1001/jamanetworkopen.2020.20969.
Abstract
This cross-sectional study assesses drug coverage, formulary restrictions, median retail prices, and annual out-of-pocket costs associated with commonly used insulin products across Medicare Part D plans.
摘要
本横断面研究评估了 Medicare Part D 计划中常用胰岛素产品的药物覆盖范围、处方限制、零售价格中位数和年度自付费用。
Zotero 插件